AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 1986658 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol 3 mg.kg‐1
Number of subjects: 21
Study 1986658 — intervention group
Group type: COMPARATOR
Intervention: Propofol 5 mg.kg‐1
Number of subjects: 21
Study 1986658 — intervention group
Group type: COMPARATOR
Intervention: Thiopental 5‐7 mg.kg‐1
Number of subjects: 21
Study 6642069 — intervention group
Group type: EXPERIMENTAL
Intervention: 500 mg of enteric-coated erythromycin base (Ery-Max) administered twice daily for 10 days
Number of subjects: 220
Study 6642069 — intervention group
Group type: COMPARATOR
Intervention: 250 mg of enteric-coated erythromycin base (Ery-Max) administered four times daily for 10 days
Number of subjects: 220
Study 6642069 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment with enteric-coated erythromycin base (Ery-Max)
Number of subjects: 220
Study 30156338 — intervention group
Group type: EXPERIMENTAL
Intervention: Oronasal mask with auto-titrating positive airway pressure (APAP) for 2 weeks
Number of subjects: 60
Study 30156338 — intervention group
Group type: COMPARATOR
Intervention: Nasal mask with auto-titrating positive airway pressure (APAP) for 2 weeks
Number of subjects: 60
Study 30350405 — intervention group
Group type: EXPERIMENTAL
Intervention: Respiratory muscle endurance training (RMET)
Number of subjects: 16
Study 30350405 — intervention group
Group type: COMPARATOR
Intervention: Control (CTRL)
Number of subjects: 16
Study 26897389 — intervention group
Group type: EXPERIMENTAL
Intervention: SMART regimen (budesonide/formoterol 200/6-µg metered dose inhaler for maintenance and reliever therapy)
Number of subjects: 303
Study 26897389 — intervention group
Group type: COMPARATOR
Intervention: Standard regimen (salbutamol 100 µg 1-2 actuations for symptom relief)
Number of subjects: 303
Study 25111218 — intervention group
Group type: COMPARATOR
Intervention: ACD
Number of subjects: 15
Study 25111218 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane with ACD
Number of subjects: 15
Study 23917766 — intervention group
Group type: EXPERIMENTAL
Intervention: Early mobilization protocol (n=14)
Number of subjects: 59
Study 23917766 — intervention group
Group type: COMPARATOR
Intervention: Conventional physical therapy (control group, n=14)
Number of subjects: 59
Study 19575501 — intervention group
Group type: EXPERIMENTAL
Intervention: Esophagogastric anterior wall end-to-side anastomosis combined with pyloroplasty (EA group)
Number of subjects: 149
Study 19575501 — intervention group
Group type: COMPARATOR
Intervention: Esophagogastric posterior wall end-to-side anastomosis (EP group)
Number of subjects: 149
Study 19575501 — intervention group
Group type: COMPARATOR
Intervention: Esophagogastric end-to-end anastomosis (EE group)
Number of subjects: 149
Study 17498016 — intervention group
Group type: EXPERIMENTAL
Intervention: Rectal paracetamol (20‐25 mg x kg(‐1)) at the third hour
Number of subjects: 202
Study 17498016 — intervention group
Group type: EXPERIMENTAL
Intervention: Rectal paracetamol (20‐25 mg x kg(‐1)) at the fourth hour
Number of subjects: 202
Study 17498016 — intervention group
Group type: COMPARATOR
Intervention: Control group (no analgesic until pain score of 5 or higher)
Number of subjects: 202
Study 14634860 — intervention group
Group type: EXPERIMENTAL
Intervention: Maintenance iron therapy (6 mg/kg per month)
Number of subjects: 0
Study 14634860 — intervention group
Group type: COMPARATOR
Intervention: Intermittent iron therapy (14.4 mg/kg per month)
Number of subjects: 0
Study 10852322 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramedullary nailing
Number of subjects: 53
Study 10852322 — intervention group
Group type: COMPARATOR
Intervention: Plaster cast
Number of subjects: 53
Study 9327818 — intervention group
Group type: EXPERIMENTAL
Intervention: Home exercise program (n = 14)
Number of subjects: 28
Study 9327818 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 14)
Number of subjects: 28
Study 9327818 — intervention group
Group type: EXPERIMENTAL
Intervention: Individuals with CPN
Number of subjects: 28
Study 8403132 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal anaesthesia (SAB) with plain 0.5% bupivacaine (15 mg) and 0.2 mg epinephrine added
Number of subjects: 60
Study 8403132 — intervention group
Group type: EXPERIMENTAL
Intervention: Lumbar epidural anaesthesia (EA) with 2% mepivacaine and 1:200,000 epinephrine added
Number of subjects: 60
Study 8403132 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural anaesthesia (AEA) with the same solution alkalinized with bicarbonate
Number of subjects: 60
Study 3533469 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous fluorouracil (5‐FU) in two courses, four and eight weeks after surgery
Number of subjects: 128
Study 3533469 — intervention group
Group type: COMPARATOR
Intervention: Control group (no chemotherapy)
Number of subjects: 128
Study 3042643 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketoprofen gel
Number of subjects: 36
Study 3042643 — intervention group
Group type: EXPERIMENTAL
Intervention: Etofenamate gel
Number of subjects: 36
Study 30753901 — intervention group
Group type: EXPERIMENTAL
Intervention: Lateral position on the same side of the fetal spine
Number of subjects: 0
Study 30753901 — intervention group
Group type: EXPERIMENTAL
Intervention: Obstetrical forceps
Number of subjects: 0
Study 30753901 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual rotation
Number of subjects: 0
Study 30753901 — intervention group
Group type: EXPERIMENTAL
Intervention: Thierry's spatulas
Number of subjects: 0
Study 28639564 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-session executive skill training program
Number of subjects: 38
Study 28639564 — intervention group
Group type: COMPARATOR
Intervention: Healthy control group
Number of subjects: 38
Study 25036283 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound
Number of subjects: 128
Study 25036283 — intervention group
Group type: COMPARATOR
Intervention: Palpation
Number of subjects: 128
Study 22771145 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-step facilitation treatment
Number of subjects: 180
Study 22771145 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-morbid functioning (FrSBe-Total)
Number of subjects: 180
Study 22771145 — intervention group
Group type: EXPERIMENTAL
Intervention: Current functioning (FrSBe-Total)
Number of subjects: 180
Study 21647654 — intervention group
Group type: EXPERIMENTAL
Intervention: Rifaximin 1,200 mg daily for 10 days
Number of subjects: 50
Study 21647654 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 21647654 — intervention group
Group type: EXPERIMENTAL
Intervention: Rifaximin
Number of subjects: 50
Study 17909084 — intervention group
Group type: EXPERIMENTAL
Intervention: pioglitazone (PIO group; 45 mg/day)
Number of subjects: 30
Study 17909084 — intervention group
Group type: EXPERIMENTAL
Intervention: ramipril (RAM group; 10 mg/day)
Number of subjects: 30
Study 17909084 — intervention group
Group type: COMPARATOR
Intervention: placebo (PLC group)
Number of subjects: 30
Study 15901651 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnetic resonance imaging and computational surface‐based methods to encode hemispheric differences in callosal thickness.
Number of subjects: 0
Study 15901651 — intervention group
Group type: EXPERIMENTAL
Intervention: Examination of parasagittal callosal asymmetries within each gender.
Number of subjects: 0
Study 12760989 — intervention group
Group type: EXPERIMENTAL
Intervention: Remifentanil (2 and 4 ng/mL)
Number of subjects: 24
Study 12760989 — intervention group
Group type: EXPERIMENTAL
Intervention: Remifentanil (1 to 100 micro g/h)
Number of subjects: 24
Study 10847536 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided tissue regeneration (GTR) treatment with a resorbable polylactic acid (PLA) barrier
Number of subjects: 20
Study 10847536 — intervention group
Group type: COMPARATOR
Intervention: Control site (no barrier placed)
Number of subjects: 20
Study 9171787 — intervention group
Group type: EXPERIMENTAL
Intervention: Breath-hold magnetic resonance cholangio-pancreatography (MRCP)
Number of subjects: 19
Study 9171787 — intervention group
Group type: COMPARATOR
Intervention: Endoscopic retrograde cholangio-pancreatography (ERCP)
Number of subjects: 19
Study 8256770 — intervention group
Group type: EXPERIMENTAL
Intervention: Aminoglutethimide and hydrocortisone acetate with tamoxifen continuation
Number of subjects: 0
Study 8256770 — intervention group
Group type: COMPARATOR
Intervention: Aminoglutethimide and hydrocortisone acetate without tamoxifen continuation
Number of subjects: 0
Study 3519383 — intervention group
Group type: EXPERIMENTAL
Intervention: Defibrotide
Number of subjects: 52
Study 3519383 — intervention group
Group type: COMPARATOR
Intervention: Dipyridamole
Number of subjects: 52
Study 30104114 — intervention group
Group type: EXPERIMENTAL
Intervention: BRV-PV
Number of subjects: 1500
Study 30104114 — intervention group
Group type: COMPARATOR
Intervention: Rotarix
Number of subjects: 1500
Study 26508503 — intervention group
Group type: EXPERIMENTAL
Intervention: Iguratimod plus methotrexate (MTX)
Number of subjects: 131
Study 26508503 — intervention group
Group type: COMPARATOR
Intervention: Iguratimod (25 mg, twice daily, orally)
Number of subjects: 131
Study 26508503 — intervention group
Group type: COMPARATOR
Intervention: Methotrexate (weekly dose of 10 mg, orally)
Number of subjects: 131
Study 24838085 — intervention group
Group type: EXPERIMENTAL
Intervention: Trained healthcare personnel
Number of subjects: 111
Study 24838085 — intervention group
Group type: COMPARATOR
Intervention: Trained nurses
Number of subjects: 111
Study 24838085 — intervention group
Group type: EXPERIMENTAL
Intervention: Trained nurse aids
Number of subjects: 111
Study 24838085 — intervention group
Group type: EXPERIMENTAL
Intervention: Trained housekeepers
Number of subjects: 111
Study 22840618 — intervention group
Group type: COMPARATOR
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 75
Study 22840618 — intervention group
Group type: EXPERIMENTAL
Intervention: Chinese Chan-based Dejian Mind-Body Intervention (DMBI)
Number of subjects: 75
Study 20138384 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalized exercise prescription by a physical therapist over a 2‐y intervention period
Number of subjects: 74
Study 20138384 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 74
Study 18702903 — intervention group
Group type: EXPERIMENTAL
Intervention: PARI sinus nebulizer (3 minutes of nebulization bilaterally)
Number of subjects: 14
Study 18702903 — intervention group
Group type: COMPARATOR
Intervention: Nasal douching with a 200‐mL nasal irrigation bottle (one standardized squeeze bilaterally)
Number of subjects: 14
Study 15888510 — intervention group
Group type: EXPERIMENTAL
Intervention: lorazepam (1 mg)
Number of subjects: 18
Study 15888510 — intervention group
Group type: EXPERIMENTAL
Intervention: lorazepam (2 mg)
Number of subjects: 18
Study 15888510 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 18
Study 15888510 — intervention group
Group type: EXPERIMENTAL
Intervention: THREAT condition
Number of subjects: 18
Study 12810142 — intervention group
Group type: EXPERIMENTAL
Intervention: Buprenorphine 1 mg
Number of subjects: 164
Study 12810142 — intervention group
Group type: EXPERIMENTAL
Intervention: Buprenorphine 3 mg
Number of subjects: 164
Study 12810142 — intervention group
Group type: EXPERIMENTAL
Intervention: Buprenorphine 8 mg
Number of subjects: 164
Study 12810142 — intervention group
Group type: EXPERIMENTAL
Intervention: Methadone 30 mg
Number of subjects: 164
Study 10661397 — intervention group
Group type: EXPERIMENTAL
Intervention: Alternative analysis methods for randomized cluster trials
Number of subjects: 0
Study 10661397 — intervention group
Group type: COMPARATOR
Intervention: Typical Pearson's chi2 analysis
Number of subjects: 0
Study 9181278 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide
Number of subjects: 1292
Study 9181278 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1292
Study 9181278 — intervention group
Group type: EXPERIMENTAL
Intervention: Diltiazem
Number of subjects: 1292
Study 9181278 — intervention group
Group type: EXPERIMENTAL
Intervention: Prazosin
Number of subjects: 1292
Study 9181278 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol
Number of subjects: 1292
Study 9181278 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine
Number of subjects: 1292
Study 9181278 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril
Number of subjects: 1292
Study 9181278 — intervention group
Group type: EXPERIMENTAL
Intervention: All treatments (including placebo)
Number of subjects: 1292
Study 8246650 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisone
Number of subjects: 76
Study 8246650 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 76
Study 3464721 — intervention group
Group type: EXPERIMENTAL
Intervention: Strontium glass filled composite (Profile)
Number of subjects: 49
Study 3464721 — intervention group
Group type: EXPERIMENTAL
Intervention: Microfilled composite (Estic MF)
Number of subjects: 49
Study 3464721 — intervention group
Group type: EXPERIMENTAL
Intervention: Macrofilled composite (Adaptic Radiopaque)
Number of subjects: 49
Study 3464721 — intervention group
Group type: COMPARATOR
Intervention: High copper amalgam (Dispersalloy)
Number of subjects: 49
Study 29772609 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardized electronic message four times/week for 6 months postpartum
Number of subjects: 0
Study 29772609 — intervention group
Group type: EXPERIMENTAL
Intervention: Messages and option to request a call from a nurse
Number of subjects: 0
Study 29772609 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study 27939846 — intervention group
Group type: EXPERIMENTAL
Intervention: MPathic-VR
Number of subjects: 421
Study 27939846 — intervention group
Group type: COMPARATOR
Intervention: Computer-based learning
Number of subjects: 421
Study 26700832 — intervention group
Group type: EXPERIMENTAL
Intervention: ACC/AHA risk-based approach
Number of subjects: 37892
Study 26700832 — intervention group
Group type: COMPARATOR
Intervention: Trial-based approach
Number of subjects: 37892
Study 26700832 — intervention group
Group type: COMPARATOR
Intervention: Hybrid approach
Number of subjects: 37892
Study 23560515 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided Care
Number of subjects: 14
Study 23560515 — intervention group
Group type: COMPARATOR
Intervention: Usual Care
Number of subjects: 14
Study 21051087 — intervention group
Group type: EXPERIMENTAL
Intervention: Interpersonal Psychotherapy (IPT)
Number of subjects: 69
Study 21051087 — intervention group
Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 69
Study 18566340 — intervention group
Group type: EXPERIMENTAL
Intervention: Multisystemic therapy (MST)
Number of subjects: 127
Study 18566340 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard medical care)
Number of subjects: 127
Study 16641430 — intervention group
Group type: EXPERIMENTAL
Intervention: FTC plus CLV (200 mg FTC QD + 10 mg CLV QD)
Number of subjects: 163
Study 16641430 — intervention group
Group type: COMPARATOR
Intervention: FTC alone (200 mg FTC QD + placebo)
Number of subjects: 163
Study 16641430 — intervention group
Group type: EXPERIMENTAL
Intervention: FTC plus CLV
Number of subjects: 163
Study 16641430 — intervention group
Group type: COMPARATOR
Intervention: FTC alone
Number of subjects: 163
Study 12548251 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-day drainage bag change
Number of subjects: 153
Study 12548251 — intervention group
Group type: COMPARATOR
Intervention: No change regimen
Number of subjects: 153
Study 10370615 — intervention group
Group type: EXPERIMENTAL
Intervention: Stop-flow thoracic perfusion with systemic chemotherapy and inhalation IL-2 immunotherapy (Group B)
Number of subjects: 67
Study 10370615 — intervention group
Group type: COMPARATOR
Intervention: Stop-flow thoracic perfusion with systemic chemotherapy without inhalation IL-2 immunotherapy (Group A)
Number of subjects: 67
Study 8670532 — intervention group
Group type: EXPERIMENTAL
Intervention: Salmeterol 50 microg bd
Number of subjects: 28
Study 8670532 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study 1667754 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentoxifylline 1 g infusion
Number of subjects: 10
Study 1667754 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 7198873 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.25% dibucaine
Number of subjects: 30
Study 7198873 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% tetracaine
Number of subjects: 30
Study 31377278 — intervention group
Group type: EXPERIMENTAL
Intervention: Micro-Stent implantation plus phacoemulsification
Number of subjects: 349
Study 31377278 — intervention group
Group type: COMPARATOR
Intervention: Phacoemulsification alone (Control)
Number of subjects: 349
Study 28257146 — intervention group
Group type: EXPERIMENTAL
Intervention: Neurofeedback (NFB) group
Number of subjects: 62
Study 28257146 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control (WLC) group
Number of subjects: 62
Study 26340544 — intervention group
Group type: EXPERIMENTAL
Intervention: MVPCI
Number of subjects: 543434
Study 23819882 — intervention group
Group type: EXPERIMENTAL
Intervention: Midwifery continuity of care through pregnancy, labour, birth and early postnatal care.
Number of subjects: 0
Study 23819882 — intervention group
Group type: COMPARATOR
Intervention: Standard hospital care from different midwives through pregnancy, labour, birth and early postnatal care.
Number of subjects: 0
Study 22963588 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise on Prescription (EoP) - 18 sessions of supervised physical activity
Number of subjects: 514
Study 22963588 — intervention group
Group type: COMPARATOR
Intervention: Care as usual (Control group)
Number of subjects: 514
Study 22963588 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise on Prescription (EoP)
Number of subjects: 514
Study 20017866 — intervention group
Group type: EXPERIMENTAL
Intervention: Caudal block
Number of subjects: 38
Study 20017866 — intervention group
Group type: COMPARATOR
Intervention: i.v. fentanyl
Number of subjects: 38
Study 17565168 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided action training
Number of subjects: 0
Study 17565168 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided attention training
Number of subjects: 0
Study 15450646 — intervention group
Group type: EXPERIMENTAL
Intervention: Relational Psychotherapy Mothers' Group (RPMG)
Number of subjects: 52
Study 15450646 — intervention group
Group type: COMPARATOR
Intervention: Standard Drug Counseling (DC)
Number of subjects: 52
Study 11380069 — intervention group
Group type: EXPERIMENTAL
Intervention: Test isosorbide dinitrate sublingual tablet (5 mg)
Number of subjects: 20
Study 11380069 — intervention group
Group type: COMPARATOR
Intervention: Reference isosorbide dinitrate sublingual tablet (5 mg)
Number of subjects: 20
Study 9530481 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined application of pulse oximetry and capnometry
Number of subjects: 48
Study 9530481 — intervention group
Group type: COMPARATOR
Intervention: Standard monitoring without pulse oximetry and capnometry
Number of subjects: 48
Study 8527291 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 micrograms PGE1
Number of subjects: 12
Study 8527291 — intervention group
Group type: EXPERIMENTAL
Intervention: 60 micrograms PGE1
Number of subjects: 12
Study 8527291 — intervention group
Group type: EXPERIMENTAL
Intervention: 120 micrograms PGE1
Number of subjects: 12
Study 8527291 — intervention group
Group type: EXPERIMENTAL
Intervention: 30-120 micrograms PGE1
Number of subjects: 12
Study 2233904 — intervention group
Group type: EXPERIMENTAL
Intervention: H. influenzae type b capsular polysaccharide-diphtheria toxoid conjugate vaccine (PRP-D) administered at ages 3, 4, 6, and 14 to 18 months
Number of subjects: 114000
Study 2233904 — intervention group
Group type: COMPARATOR
Intervention: Control group receiving the same vaccine at the age of 24 months
Number of subjects: 114000
Study 2233904 — intervention group
Group type: EXPERIMENTAL
Intervention: H. influenzae type b capsular polysaccharide-diphtheria toxoid conjugate vaccine (PRP-D)
Number of subjects: 114000
Study 452871 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mg of quinestrol (oral, one tablet once a month)
Number of subjects: 70
Study 452871 — intervention group
Group type: COMPARATOR
Intervention: Placebo (oral, one tablet once a month)
Number of subjects: 70
Study 31028894 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone propionate and salmeterol
Number of subjects: 3416
Study 31028894 — intervention group
Group type: COMPARATOR
Intervention: Fluticasone propionate
Number of subjects: 3416
Study 28088380 — intervention group
Group type: EXPERIMENTAL
Intervention: Aquatic exercise therapy (45min, twice a week for 6 weeks)
Number of subjects: 21
Study 28088380 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 21
Study 25832538 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimedia source material plus the Internet platform of Joint Registration System
Number of subjects: 300
Study 25832538 — intervention group
Group type: COMPARATOR
Intervention: Traditional education
Number of subjects: 300
Study 24713186 — intervention group
Group type: EXPERIMENTAL
Intervention: Sofosbuvir (SOF) + Ribavirin (RBV) for 12 weeks
Number of subjects: 334
Study 24713186 — intervention group
Group type: EXPERIMENTAL
Intervention: Sofosbuvir (SOF) + Ribavirin (RBV) for 24 weeks
Number of subjects: 334
Study 24713186 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients achieving SVR-12 (regardless of regimen)
Number of subjects: 334
Study 22446169 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance training (RT) - 1 set
Number of subjects: 0
Study 22446169 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance training (RT) - 3 sets
Number of subjects: 0
Study 22446169 — intervention group
Group type: COMPARATOR
Intervention: Non-exercise control
Number of subjects: 0
Study 19411061 — intervention group
Group type: EXPERIMENTAL
Intervention: Low dose propranolol
Number of subjects: 54
Study 19411061 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 54
Study 17241875 — intervention group
Group type: EXPERIMENTAL
Intervention: Angiotensin II
Number of subjects: 0
Study 17241875 — intervention group
Group type: COMPARATOR
Intervention: AT(1) receptor antagonist losartan
Number of subjects: 0
Study 17241875 — intervention group
Group type: COMPARATOR
Intervention: AT(1) receptor antagonist candesartan
Number of subjects: 0
Study 17241875 — intervention group
Group type: COMPARATOR
Intervention: Candesartan
Number of subjects: 0
Study 15717509 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinetic therapy (KT) with propofol sedation
Number of subjects: 46
Study 15717509 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinetic therapy (KT) without propofol sedation
Number of subjects: 46